Application 202377

Type
ANDA
Sponsor
TORRENT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANTABLET;ORALEQ 5MG BASE;160MGNoNo
002AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANTABLET;ORALEQ 5MG BASE;320MGNoNo
003AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANTABLET;ORALEQ 10MG BASE;160MGNoNo
004AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANTABLET;ORALEQ 10MG BASE;320MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A202377-001AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-30
A202377-002AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-30
A202377-003AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-30
A202377-004AMLODIPINE BESYLATE AND VALSARTANAMLODIPINE BESYLATE; VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-30d06236e962d9…
2024-10-29 15:01 UTC2024-10A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-30d06236e962d9…
2024-10-29 15:01 UTC2024-10A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-30d06236e962d9…
2024-10-29 15:01 UTC2024-10A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A202377-001AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;160MGTABLET / ORAL2015-03-304b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A202377-002AMLODIPINE BESYLATE AND VALSARTANEQ 5MG BASE;320MGTABLET / ORAL2015-03-304b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A202377-003AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;160MGTABLET / ORAL2015-03-304b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A202377-004AMLODIPINE BESYLATE AND VALSARTANEQ 10MG BASE;320MGTABLET / ORAL2015-03-304b0b4de00fa7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A202377-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A202377-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A202377-003AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A202377-004AB174a2ff9319b5…
2019-09-15 20:21 UTC2019-09A202377-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A202377-002AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A202377-003AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A202377-004AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A202377-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A202377-002AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A202377-003AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A202377-004AB1ea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13668-204Amlodipine and ValsartanAmlodipine and ValsartanTorrent Pharmaceuticals LimitedANDACurrent
13668-205Amlodipine and ValsartanAmlodipine and ValsartanTorrent Pharmaceuticals LimitedANDACurrent
13668-205Amlodipine and ValsartanAmlodipine and ValsartanTorrent Pharmaceuticals LimitedANDACurrent
13668-206Amlodipine and ValsartanAmlodipine and ValsartanTorrent Pharmaceuticals LimitedANDACurrent
13668-207Amlodipine and ValsartanAmlodipine and ValsartanTorrent Pharmaceuticals LimitedANDACurrent